MKC253 Inhalation Powder

DRUG2 trials

Sponsors

Mannkind Corporation

Conditions

Diabetes Mellitus, Type 2Healthy Males

Phase 1

A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males

CompletedNCT00475371

Mannkind CorporationDiabetes Mellitus, Type 2, Healthy Males

Start: 2007-04-30Updated: 2012-06-14

A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellitus

CompletedNCT00642538

Mannkind CorporationDiabetes Mellitus, Type 2

Start: 2008-02-29End: 2008-09-30Updated: 2012-06-14